Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: An 11-year single-centre study

Digestive Surgery

Volumn 30, Issue 4-6, 2014, Pages 293-301

  John, S K P ^a   Robinson, S M ^a   Rehman, S ^a   Harrison, B ^a   Vallance, A ^a   French, J J ^a   Jaques, B C ^a   Charnley, R M ^a   Manas, D M ^a   White, S A ^a  

^a FREEMAN HOSPITAL   (United Kingdom)

Author keywords

Colorectal cancer; Liver metastasis; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT; CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD; CANCER GRADING; COLORECTAL TUMOR; FEMALE; FOLLOW UP; HUMAN; LIVER RESECTION; LIVER TUMOR; LYMPH NODE METASTASIS; MALE; METASTASIS; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PREOPERATIVE CARE; PROGNOSIS; REOPERATION; RETROSPECTIVE STUDY; SURVIVAL RATE; TUMOR INVASION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM INVASIVENESS; PREOPERATIVE CARE; PROGNOSIS; REOPERATION; RETROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84896294702     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000354310     Document Type: Article

References (46)

1. Jemal A, Siegel R, Xu J, Ward E: Cancer statistics. CA Cancer J Clin 2010; 60: 277-300
2. American Cancer Society: Cancer facts and figures. Atlanta, American Cancer Society, 2010
3. UK Cancer Research: Bowel cancer survival statistics. London, UK Cancer Research, 2009
4. Bengmark S HL: The natural history of primary and secondary malignant tumors of the liver. 1. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy. Cancer 1969; 23: 198-202
5. Bengtsson G CG, Hafströ m L, Jö nsson PE: Natural history of patients with untreated liver metastases from colorectal cancer. Am J Surg 1981; 141: 586-589
6. Leporrier J MJ, Chiche L, Bara S, Segol P, Launoy G: A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer. Br J Surg 2006; 93: 465-474
7. Taylor M, Chu L, Sugrue M, Dong W: Median survival in newly diagnosed metastatic colorectal cancer patients and its variability by age and comorbidity; in 2008 Gastrointestinal Cancers Symposium, Orlando, January 2008
8. Stangl R, Altendorf-Hofmann A, Charnley RM, Scheele J: Factors influencing the natural history of colorectal liver metastases. Lancet 1994; 343: 1405-1410
9. Lochan R, White SA, Manas DM: Liver resection for colorectal liver metastasis. Surg Oncol 2007; 16: 33-45
10. Choti MA, Sitzmann JV, Tiburi MF, Sumetchotimetha W, Rangsin R, Schulick RD, et al: Trends in long-Term survival following liver resection for hepatic colorectal metastases. Ann Surg 2002; 235: 759-766
11. Rees M TP, Welsh FK, O'Rourke T, John TG: Evaluation of long-Term survival after hepatic resection for metastatic colorectal cancer: A multifactorial model of 929 patients. Ann Surg 2008; 247: 125-135
12. Fernandez FG, Drebin JA, Linehan DC, Dehdashti F, Siegel BA, Strasberg SM: Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg 2004; 240: 438-447, discussion 447-450
13. Abdalla EK VJ, Ellis LM, Ellis V, Pollock R, Broglio KR, Hess K, Curley SA: Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ ablation for colorectal liver metastases. Ann Surg 2004; 239: 818-825
14. House MG, Ito H, Gonen M, Fong Y, Allen PJ, DeMatteo RP, et al: Survival after hepatic resection for metastatic colorectal cancer: Trends in outcomes for 1,600 patients during two decades at a single institution. J Am Coll Surg 2010; 210: 744-752, 752-755
15. Tanaka K, Adam R, Shimada H, Azoulay D, Levi F, Bismuth H: Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver. Br J Surg 2003; 90: 963-969
16. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH: Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases. Ann Surg 1999; 230: 309-318, discussion 318-321
17. Lin JK, Lin CC, Yang SH, Wang HS, Jiang JK, Lan YT, et al: Early postoperative CEA level is a better prognostic indicator than is preoperative CEA level in predicting prognosis of patients with curable colorectal cancer. Int J Colorect Dis 2011; 26: 1135-1141
18. Malik HZ, Gomez D, Wong V, Al-Mukthar A, Toogood GJ, Lodge JP, et al: Predictors of early disease recurrence following hepatic resection for colorectal cancer metastasis. Eur J Surg Oncol 2007; 33: 1003-1009
19. Blumgart LH, Fong Y: Surgical options in the treatment of hepatic metastasis from colorectal cancer. Curr Problems Surg 1995; 32: 333-421
20. Nordlinger B, Guiguet M, Vaillant JC, Balladur P, Boudjema K, Bachellier P, et al: Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association FranCaise de Chirurgie. Cancer 1996; 77: 1254-1262
21. Cady B, Jenkins RL, Steele GD Jr, Lewis WD, Stone MD, McDermott WV, et al: Surgical margin in hepatic resection for colorectal metastasis: A critical and improvable determinant of outcome. Ann Surg 1998; 227: 566-571
22. Kanas GP TA, Primrose JN, Langeberg WJ, Kelsh MA, Mowat FS, Alexander DD, Choti MA, Poston G: Survival after liver resection in metastatic colorectal cancer: Review and meta-Analysis of prognostic factors. Clin Epidemiol 2012; 4: 283-301
23. Are C, Gonen M, Zazzali K, Dematteo RP, Jarnagin WR, Fong Y, et al: The impact of margins on outcome after hepatic resection for colorectal metastasis. Ann Surg 2007; 246: 295-300
24. Hamady ZZ, Cameron IC, Wyatt J, Prasad RK, Toogood GJ, Lodge JP: Resection margin in patients undergoing hepatectomy for colorectal liver metastasis: A critical appraisal of the 1 cm rule. Eur J Surg Oncol 2006; 32: 557-563
25. Spelt L, Andersson B, Nilsson J, Andersson R: Prognostic models for outcome following liver resection for colorectal cancer metastases: A systematic review. Eur J Surg Oncol 2012; 38: 16-24
26. Yuman Fong JF, Sun RL, Brennan MF, Blumgart LH: Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer analysis of 1001 consecutive cases. Ann Surg 1999; 230: 318-321
27. Malik HZ PK, Halazun KJ, Aldoori A, Al-Mukhtar A, Gomez D, Lodge JP, Toogood GJ: SOURCE. Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases. Ann Surg 2007; 246: 806-814
28. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): A randomised controlled trial. Lancet 2008; 371: 1007-1016
29. Minagawa M YJ, Kosuge T, Matsuyama Y, Miyagawa S, Makuuchi M: Simplified staging system for predicting the prognosis of patients with resectable liver metastasis: Development and validation. Arch Surg 2007; 142: 269-276
30. Yamaguchi T, Mori T, Takahashi K, Matsumoto H, Miyamoto H, Kato T: A new classification system for liver metastases from colorectal cancer in Japanese multicenter analysis. Hepatogastroenterology 2008; 55: 173-178
31. Konopke R KS, Distler M, Dietrich J, Gastmeier J, Heller A, Kulisch E, Saeger HD: Prognostic factors and evaluation of a clinical score for predicting survival after resection of colorectal liver metastases. Liver Int 2009; 29: 89-102
32. Zakaria S, Donohue JH, Que FG, Farnell MB, Schleck CD, Ilstrup DM, et al: Hepatic resection for colorectal metastases: Value for risk scoring systems?. Ann Surg 2007; 246: 183-191
33. Tan MC, Castaldo ET, Gao F, Chari RS, Linehan DC, Wright JK, et al: A prognostic system applicable to patients with resectable liver metastasis from colorectal carcinoma staged by positron emission tomography with [18F] fluoro-2-deoxy- D -glucose: Role of primary tumor variables. J Am Coll Surg 2008; 206: 857-868, discussion 868-869
34. Pawlik TM, Scoggins CR, Zorzi D, Abdalla EK, Andres A, Eng C, et al: Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 2005; 241: 715-722, discussion 722-724
35. Welsh FK TP, O'Rourke T, John TG, Rees M: Quantification of risk of a positive (R1) resection margin following hepatic resection for metastatic colorectal cancer: An aid to clinical decision-making. Surg Oncol 2008; 17: 3-13
36. Arru M, Aldrighetti L, Castoldi R, Di Palo S, Orsenigo E, Stella M, et al: Analysis of prognostic factors influencing long-Term survival after hepatic resection for metastatic colorectal cancer. World J Surg 2008; 32: 93-103
37. Sasaki A, Iwashita Y, Shibata K, Matsumoto T, Ohta M, Kitano S: Analysis of preoperative prognostic factors for long-Term survival after hepatic resection of liver metastasis of colorectal carcinoma. J Gastrointest Surg 2005; 9: 374-380
38. Aldrighetti L, Castoldi R, Di Palo S, Arru M, Stella M, Orsenigo E, et al: Prognostic factors for long-Term outcome of hepatic resection for colorectal liver metastases (in Italian). Chir Ital 2005; 57: 555-570
39. Weber SM JW, DeMatteo RP, Blumgart LH, Fong Y: Survival after resection of multiple hepatic colorectal metastases. Ann Surg Oncol 2000; 7: 643-650
40. Scheele J, Stang R, Altendorf-Hofmann A, Paul M: Resection of colorectal liver metastases. World J Surg 1995; 19: 59-71
41. Pilati P, Mocellin S, Bertazza L, Galdi F, Briarava M, Mammano E, et al: Prognostic value of putative circulating cancer stem cells in patients undergoing hepatic resection for colorectal liver metastasis. Ann Surg Oncol 2012; 19: 402-408
42. Hinz S BJ, Rö der C, Egberts JH, Schafmayer C, Küchler T, Becker T, Kalthoff H: Disseminated tumor cells in the bone marrow negatively influence survival after resection of colorectal liver metastases. Ann Surg Oncol 2012; 19: 2539-2546
43. Kang S, Maeda K, Chung Y, Onoda N, Ogawa Y, Takatsuka S, et al: Vascular endothelial growth factor expression correlates with hematogenous metastasis and prognosis in colorectal carcinoma. Oncol Rep 1997; 4: 381-384
44. Shen YM, Arbman G, Sandstrom P, Gullstrand P, Wei YQ, Zhang H, et al: Novel gene hBiot2 is an independent prognostic factor in colorectal cancer patients. Oncol Rep 2012; 27: 376-382
45. Kim HR, Min BS, Kim JS, Shin SJ, Ahn JB, Rho JK, et al: Efficacy of oxaliplatin-based chemotherapy in curatively resected colorectal cancer with liver metastasis. Oncology 2011; 81: 175-183
46. Maithel SK GM, Ito H, Dematteo RP, Allen PJ, Fong Y, Blumgart LH, Jarnagin WR, D'Angelica MI: Improving the clinical risk score: An analysis of molecular biomarkers in the era of modern chemotherapy for resectable hepatic colorectal cancer metastases. Surgery 2012; 151: 162-170